News | July 13, 2022
Heathcare startup MedTel to raise around USD 10mn in Series A
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
The vaccine is under FDA review
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
It is a two dose vaccine to be administered intramuscularly at 28 days apart
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Subscribe To Our Newsletter & Stay Updated
